Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.53 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propoxicam SCHEMBL29685544 | 0.97 | PTGS1 (0.54) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| SCHEMBL27916598 | 0.87 | HSD11B1 (0.58) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| SCHEMBL6797674 | 0.86 | PTGS1 (0.57) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| SCHEMBL6803658 | 0.86 | HSD11B1 (0.54) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| SCHEMBL6802158 | 0.85 | PTGS1 (0.56) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| Iodide SCHEMBL6802074 | 0.83 | PTGS1 (0.54) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| SCHEMBL6793771 | 0.83 | CAPN1 (0.53) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| SCHEMBL27595835 | 0.82 | PTGS1 (0.58) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| Iodide SCHEMBL6792333 | 0.82 | PTGS1 (0.53) | PTGS1PTGS2KDM4EUSP2CYP1A2 | |
| SCHEMBL10959224 | 0.81 | HSD11B1 (0.64) | PTGS1PTGS2KDM4EUSP2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063696-A1 | 1,1-dioxo-2h-1,2-benzothiazine-3-carboxamide derivatives,method for preparing same and pharmaceutical compositions comprising same | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2004-04-01 | — | — | US | disclosed |
| CN-1481372-A | 1,1-dioxo-2H-1,2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compsns comprising same | ɪά��ʵ���� | 2004-03-10 | — | — | CN | disclosed |
| EP-1343774-A1 | 1,1-DIOXO-2H-1, 2-BENZOTHIAZINE-3-CARBOXAMIDE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Les Laboratoires Servier (FR) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002050049-A1 | 1,1-DIOXO-2H-1, 2-BENZOTHIAZINE-3-CARBOXAMIDE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | LES LABORATOIRES SERVIER (FR) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063696-A1 | 1,1-dioxo-2h-1,2-benzothiazine-3-carboxamide derivatives,method for preparing same and pharmaceutical compositions comprising same | ADCY2, ADCY1, HRH2 | PTGS1 548/4885PTGS2 564/4885KDM4E 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.